INS and type 2 diabetes mellitus: Thus, ASCs from high-fat diet and streptozotocin-induced type 2 diabetes had inferior proliferative capacity compared to cells from healthy controls, improved insulin sensitivity and less β cell death was seen in T2D mice receiving mesenchymal stem cell therapy [35].